Search Results - "Barışta, I."

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience by Beköz, H., Karadurmuş, N., Paydaş, S., Türker, A., Toptaş, T., Fıratlı Tuğlular, T., Sönmez, M., Gülbaş, Z., Tekgündüz, E., Kaya, A.H., Özbalak, M., Taştemir, N., Kaynar, L., Yıldırım, R., Karadoğan, I., Arat, M., Pepedil Tanrıkulu, F., Özkocaman, V., Abalı, H., Turgut, M., Kurt Yüksel, M., Özcan, M., Doğu, M.H., Kabukçu Hacıoğlu, S., Barışta, I., Demirkaya, M., Köseoğlu, F.D., Toprak, S.K., Yılmaz, M., Demirkürek, H.C., Demirkol, O., Ferhanoğlu, B.

“…Reed–Sternberg cells of classical Hodgkin’s lymphoma (cHL) are characterized by genetic alterations at the9p24.1 locus, leading to over-expression of…”
Get full text

PB2135: BURKITT LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (BL‐IPI): IS IT EFFICIENT ENOUGH IN ADULT BURKITT LYMPHOMA PATIENTS? by Sayinalp, B., Barista, I., Buyukasik, Y.

Get full text

cTnT can be a useful marker for early detection of anthracycline cardiotoxicity by Kilickap, S., Barista, I., Akgul, E., Aytemir, K., Aksoyek, S., Aksoy, S., Celik, I., Kes, S., Tekuzman, G.

“…Background:: The level of serum cardiac troponin-T (cTnT) increases with myocardial damage. We sought to assess whether cTnT level could be a useful marker for…”
Get full text

Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey by Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., Toptas, T., Firatli Tuglular, T., Tekgunduz, E., Kaya, A., Tastemir, N., Arat, M., Pepedil Tanrikulu, F., Ozkocaman, V., Abali, H., Turgut, M., Kaynar, L., Karadogan, I., Ozbalak, M., Dogu, M., Kabukcu Hacioglu, S., Yildirim, R., Barista, I., Kurt Yuksel, M., Sonmez, M.

Get full text

Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey by Demiroğlu, H, Barişta, I, Dündar, S

“…Behcet's disease (BD) shows great regional differences in clinical manifestations and prognosis, including eye involvement. Thus, it is hard to predict in…”
Get more information

Reply to “Troponins in prediction of cardiotoxic effects”, by D. Cardinale et al by Kilickap, S., Barista, I., Aytemir, K.

Get full text

Biphosphonates and the flare phenomenon by Barişta, I

Get full text

Comments on “Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma” by M. Binn, A. Ruskoné-Fourmestraux, E. Lepage et al. (Ann Oncol 2003; 14: 1751–1757) by Abali, H., Barista, I.

Get full text

Comments on current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the Milan cancer institute, Bonadonna, Eur J Cancer, 32A, No. 2, pp. 209–214, 1996 by Barişta, İ.

Get full text

Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum by KOCA, E, DUMAN, A. E, OZCEBE, O. I, CETINER, D, BUYUKASIK, Y, HAZNEDAROGLU, I. C, UNER, A, DEMIRHAN, B, KERIMOGLU, U, BARISTA, I, CALGUNERI, M

“…We report successful treatment of a refractory myelodysplastic syndrome-associated pyoderma gangrenosum with the combination of thalidomide and…”
Get full text

Intrathecal cytarabine and bone marrow suppression by Barişta, I

Get full text

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma? by BARISTA, I, CABANILLAS, F, ROMAGUERA, J. E, KHOURI, I. F, YANG, Y, SMITH, T. L, STROM, S. S, MEDEIROS, L. J, HAGEMEISTER, F. B

“…To examine the frequency of additional neoplasms preceding and following the diagnosis of mantle cell lymphoma (MCL). A total of 156 patients with MCL treated…”
Get full text

Enhanced erythrocyte aggregation in type 2 diabetes with late complications by Demiroglu, H, Gürlek, A, Barişta, I

“…We investigated whether erythrocyte aggregation (EA) is enhanced in type 2 diabetic patients who have developed microvascular or macrovascular complications…”
Get more information

1504O Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer by Bas, O., Erdemir, A., Onur, R., Guner, G., Guven, D.C., Aksu, S., Kertmen, N., Aksoy, S., Barista, I., Turker, A., Dizdar, O.

Get full text

Amyloidosis in Hodgkin's and Castleman's diseases by Barişta, İ., Benekli, M., Tekuzman, G.

Get full text

A patient presenting with spinal cord compression who had two distinct follicular cell type thyroid carcinomas by Koca, E, Sokmensuer, C, Yildiz, B O, Engin, H, Bozkurt, M F, Aras, T, Barista, I, Gurlek, A

“…A 61-yr-old woman presented with complaints of weakness and pain in her legs. A magnetic resonance imaging showed a 3 x 5.6 x 7.8 cm mass lesion destructing…”
Get full text

Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy : A randomized study by YALCIN, S, TEKUZMAN, G, BALTALI, E, ÖZISIK, Y, BARISTA, I

“…In this randomized study, the efficacy of a single dose of three serotonin antagonists were compared in prophylaxis of acute and delayed vomiting induced by…”
Get full text

Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney by Yalçin S, Barişta, I, Tekuzman, G, Güllü, I, Firat, D

Get more information

Metastatic malignant blue nevus: a case report by Ozgür, F, Akyürek, M, Kayikçioğlu, A, Barişta, I, Gököz, A

“…This report presents a 63-year-old Caucasian woman with a malignant blue nevus, which is an extremely rare form of melanoma originating from or associated with…”
Get more information

An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients by Barişta, I

Get full text